Viewing FOP Through Rosi-Colored Glasses

Drs. Kaplan, Pignolo, and Shore have prepared an editorial regarding Rosiglitazone, an anti-inflammatory and anti-diabetic agent that alters the fate of marrow stromal cells. This editorial focuses on safety issues and precautions of Rosiglitazone and FOP.

Click here to read the editorial.